Skip to content

The Efficacy of Mindfulness-Based Cognitive Therapy on Self-Efficacy and Anxiety Among Epileptic Patients

S. Mohamadpour, F. Tajikzadeh, A. Aflakseir

April 30, 2017 DOI: 10.5812/archneurosci.39060 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial
Sample size 30
Population Epileptic patients in public healthcare centers of Kuhdasht, Iran
Intervention Mindfulness-based cognitive therapy (MBCT)
Duration 8 weekly sessions
Measures General Self-Efficacy Scale (GSES), Zung Self-Rating Anxiety Scale (SAS)
Topics Anxiety Meditation
Key findings MBCT produced significant differences in self-efficacy and anxiety scores between the experimental and control groups (P < 0.001); the authors conclude that MBCT can increase self-efficacy and decrease anxiety in epileptic patients.

Abstract

Objective: The aim of the present study was to investigate the efficacy of mindfulness-based cognitive therapy (MBCT) on self-efficacy and anxiety among epileptic patients.

Methods: The present study with a pretest-posttest control-group design was performed on epileptic patients in public healthcare centers of Kuhdasht, Iran. Through randomized sampling, 15 patients were selected for the experimental group and 15 epileptic patients for the control group. The experimental group received MBCT once a week during 8 sessions, while the control group was engaged in usual activities. The data collection tools included the general self-efficacy scale (GSES) and Zung self-rating anxiety scale (SAS). For statistical analysis, descriptive tests and repeated measures analysis of variance were performed.

Results: Data analysis showed significant differences in self-efficacy and anxiety scores between the experimental and control groups (P < 0.001).

Conclusions: According to the results, MBCT can increase self-efficacy and decrease anxiety in epileptic patients.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics